Analyst Ratings For DURECT (NASDAQ:DRRX)
Today, DURECT (NASDAQ:DRRX) stock received an upgrade by HC Wainwright from Neutral to Buy with a price target of $3.50.
Some recent analyst ratings include
- 3/6/2018-HC Wainwright Upgrade from a “Neutral ” rating to a ” Buy” rating.
- 10/20/2017-Stifel Nicolaus was Downgraded by analysts at Stifel Nicolaus from a “Buy ” rating to a ” Hold” rating.
- 9/27/2016-Rodman & Renshaw Reiterated Rating of Buy.
Recent Insider Trading Activity For DURECT (NASDAQ:DRRX)
DURECT (NASDAQ:DRRX) has insider ownership of 10.30% and institutional ownership of 44.30%.
- On 11/3/2016 April Fund L.P. 21, Major Shareholder, bought 95,000 with an average share price of $1.16 per share and the total transaction amounting to $110,200.00.
- On 9/26/2016 April Fund L.P. 21, Major Shareholder, bought 2,500,000 with an average share price of $1.15 per share and the total transaction amounting to $2,875,000.00.
- On 4/26/2016 April Fund L.P. 21, Major Shareholder, bought 5,500,000 with an average share price of $1.25 per share and the total transaction amounting to $6,875,000.00.
- On 4/26/2016 Dave Hoffmann, Director, bought 200,000 with an average share price of $1.25 per share and the total transaction amounting to $250,000.00.
- On 4/26/2016 Felix Theeuwes, Chairman, bought 160,000 with an average share price of $1.25 per share and the total transaction amounting to $200,000.00.
- On 3/14/2016 Armand Neukermans, Director, bought 18,000 with an average share price of $1.39 per share and the total transaction amounting to $25,020.00.
- On 3/14/2016 Felix Theeuwes, Chairman, bought 70,000 with an average share price of $1.41 per share and the total transaction amounting to $98,700.00.
Recent Trading Activity for DURECT (NASDAQ:DRRX)
Shares of DURECT closed the previous trading session at with 859612 shares trading hands.